Cancerous Statistics, by Alla Astakhova
Russian officials found an ingenious way to cure cancer and to impress their autocratic president Putin: they simply rig statistics.Continue Reading
Category: Medicine
UCL trachea transplants: Videregen sets lawyers on Liverpool academics Murray and Levy
Videregen, the Liverpool-based company which bought the trachea regeneration patent from UCL, deployed lawyers against the academics Patricia Murray and Raphael Levy, precisely via their employer University of Liverpool. Main issue is the parliamentary submission by Levy and Murray, subject to absolute privilege. Yet Videregen also cites from the confidential notice of suspected research misconduct Murray and Levy submitted in good faith to UCL.
Macchiarini victim Zhadyra Iglikova is dead
Another one of Paolo Macchiarini’s past trachea transplant patients has died on 9 July 2018. She received from Macchiarini a cadaveric decellurised trachea in December 2010. By 2018, Zhadyra’s situation critically deteriorated, the dying patient was used for another experiment. On June 5th 2018, Zhadyra received in Moscow another trachea transplant. Responsible was same Parshin who performed the first trachea transplant together with Macchiarini.
“Me llamo Paloma Cabeza Jiménez”: Macchiarini victim speaks out
Paloma was supposed to the second trachea transplant patient of Paolo Macchiarini’s in Barcelona, in summer 2008. The scandal surgeon gave her a fake diagnosis of a lethal tracheal cancer which she never had, and also “accidentally” mislocated her stent during a enforced bronchoscopy. All to coerce his patient to agree to a trachea transpalnt. Paloma had a lucky escape, twice. She namely also encountered Thorsten Walles.
Karolinska requests retraction of Macchiarini and Jungebluth papers
Karolinska Institutet announced its decision on 6 papers by their former professor and surgeon, Paolo Macchiarini. All are to be retracted, 7 scientists were found guilty of research misconduct, including one of the whistleblowers.
Karolinska gets taught German medical ethics
In the aftermath of the scandal around Paolo Macchiarini, which left many patients dead, his former employer Karolinska Institutet requested a retraction a paper. The Swiss-German medical publisher Karger and its journal Respiration however categorically refused and ordered KI not “to patronize the readers of the journal ‘Respiration’.” The German Editor-in-Chief had namely a huge conflict of interest.
UCL trachea transplant inquiry: scapegoating, obfuscation and a lost nose
In 2017, UCL invited an external expert commission to investigate the deadly trachea transplants performed by the former UCL honorary professor Paolo Macchiarini. An already sacked UCL nanotechnology professor, Alexander Seifalian, whose lab made the two UCL plastic POSS-PCU tracheas in 2011, was announced as the main culprit on UCL side. All this despite Seifalian’s having had no clinical role, training or ambitions, as he professed in his interview to the investigative committee, which I now obtained.
Macchiarini victim’s family sues trachea makers for wrongful death
Yesim Cetir was a young woman from Turkey, whose vulnerability the scandal surgeon used to test his plastic trachea (twice),Continue Reading
Trachea transplanters without borders
What with the EU phase 2 clinical trial TETRA going nowhere, the technology’s owner, Liverpool-based company Videregen decided to seek new clinical partners. Surgeons and universities from outside the EU are invited to test Videregen’s trachea transplant technology, which was originally developed together with Paolo Macchiarini by the UCL laryngologist and paid Videregen advisor Martin Birchall.
The Kathrin Maedler Dynasty
German diabetologist Kathrin Maedler is a central figure of a questionable academic dynasty. Using Photoshop simulations, she discovered a cure for diabetes, which was then allegedly validated in clinical trials led by her Swiss PhD advisor Marc Donath. 15 years later, the Maedler-Donath diabetes cure was proven as utterly ineffective by same Donath, in another clinical trial. Maedler’s own PhD student, Amin Ardestani is group leader in Bremen, despite data irregularities and unacknowledged textual reuse in his thesis.
For Better Science 